Fortune 100 companies adopt Adobe AI tools at 99% rate
William R. Shepard, a director at CME Group Inc. (NASDAQ:CME), recently acquired shares in the company valued at $64,282. According to a filing with the Securities and Exchange Commission, Shepard purchased a total of 276.02 shares of CME Group's Class A Common Stock on December 27, 2024. The shares were acquired at a price of $232.89 each. The $83.5 billion market cap company currently trades near its InvestingPro Fair Value, with analysts setting price targets between $192 and $275.
The acquisition included 11.655 shares through a dividend reinvestment plan, as noted in the filing. The remaining shares were acquired indirectly by a trust. This transaction increases Shepard's direct and indirect holdings in CME Group, with a total of 2371.84 shares held directly and 255,436.31 shares held indirectly following these transactions. CME Group boasts a robust 4.45% dividend yield and has maintained dividend payments for 22 consecutive years, with 16.85% dividend growth in the last year. InvestingPro subscribers can access detailed dividend analysis and 7 additional key insights about CME's financial health, which is rated as "GOOD" by the platform.
In other recent news, CME Group, a leading derivatives marketplace, reported significant developments. The company announced a record-setting third quarter with an adjusted EPS of $2.68 and revenue of nearly $1.6 billion, an 18% rise from the same quarter in 2023. This performance was driven by a 27% increase in average daily volume and a 36% rise in interest rate trading volume. Following these results, Oppenheimer maintained an Outperform rating on CME Group shares, while BofA Securities maintained an Underperform rating.
In addition, CME Group announced changes to its collateral fee schedule and pricing for clients. The company also plans to launch a 1-Ounce Gold futures contract in 2025, pending regulatory approval. Furthermore, CME Group has received approval from the National Futures Association to establish its own futures commission merchant, a strategic move aimed at adapting to evolving client needs.
Lastly, CME Group reported a significant trading volume for October 2024, with an average daily volume of 24.3 million contracts, marking the second-highest October ADV in the company's history. These recent developments highlight CME Group's continuous efforts to enhance its service offerings and maintain its position as a leader in the global derivatives market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.